Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,721,190
+$117,000 QoQ
Shares Held
30,125
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#269
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRED ALGER MANAGEMENT, LLC holds $736,177,545 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
4,907,570 | $235,268,905 | |
| 2 | BIIB |
Biogen Inc.
|
788,307 | $170,321,610 | |
| 3 | JNJ |
Johnson & Johnson
|
444,151 | $112,801,029 | |
| 4 | LLY |
ELI LILLY & Co
|
75,669 | $90,759,676 | |
| 5 | MRK |
Merck & Co., Inc.
|
487,735 | $62,673,947 | |
| 6 | AZN |
Astrazeneca PLC
|
138,797 | $26,318,686 | |
| 7 | ABBV |
AbbVie Inc.
|
67,742 | $17,046,596 | |
| 8 | AMGN |
Amgen Inc
|
14,074 | $5,096,476 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,721,190 | 30,125 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,604,190 | 30,142 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,158,710 | 30,164 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,846,461 | 45,590 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,781,347 | 39,512 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,049,758 | 27,357 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,558,766 | 26,295 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,024,450 | 26,295 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,799,365 | 26,295 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,364,371 | 24,443 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,154,396 | 21,337 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,910,689 | 18,758 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,921,830 | 19,045 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,752,140 | 19,045 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,645,207 | 18,135 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,270,431 | 16,714 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,244,112 | 14,718 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,170,848 | 13,343 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,093,462 | 12,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,016,934 | 12,435 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,148,802 | 12,591 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,076,278 | 12,591 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,193,123 | 12,635 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,235,045 | 25,702 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $111,015,253 | 1,271,070 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $126,163,341 | 1,530,180 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||